CASI Pharmaceuticals Inc (CASI)
NASDAQ
Fin d'année 31 Décembre 2023 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Return on Assets (%) | -56.37 | -29.582 | -34.663 | -42.614 | -41.922 | -28.609 | -34.975 | -31.44 |
Return on Equity (%) | -128.638 | -36.309 | -37.124 | -50.458 | -62.493 | -45.837 | -63.55 | -78.442 |
Return on Invested Capital (%) | -107.161 | -34.659 | -34.76 | -48.236 | -65.044 | -58.056 | -43.918 | -48.312 |
Operating Margin (%) | N/A | N/A | N/A | -1098.088 | -313.79 | -118.808 | -86.833 | -77.606 |
Net Profit Margin (%) | N/A | N/A | N/A | -1114.306 | -318.916 | -126.14 | -95.145 | -79.577 |
Book Value Per Share | 0.327 | 0.527 | 0.919 | 0.785 | 0.729 | 0.685 | 4.894 | 1.669 |
Earnings Per Share | -0.149 | -0.147 | -0.279 | -0.471 | -0.39 | -0.272 | -3.048 | -2.015 |
Cash Per Share | 0.426 | 0.594 | 0.854 | 0.548 | 0.46 | 0.277 | 3.501 | 1.277 |
Working Capital Per Share | 0.411 | 0.53 | 0.899 | 0.548 | 0.533 | 0.349 | 4.192 | 3.186 |
Operating Profit Per Share | N/A | N/A | N/A | 0.024 | 0.061 | 0.139 | 2.207 | 2.254 |
EBIT Per Share | -0.149 | -0.147 | -0.279 | -0.464 | -0.383 | -0.256 | -2.781 | -1.965 |
EBITDA Per Share | -0.149 | -0.147 | -0.279 | -0.464 | -0.383 | -0.256 | -2.781 | -1.965 |
Free Cash Flow Per Share | -0.146 | -0.136 | -0.075 | -0.417 | -0.249 | -0.221 | -2.811 | -2.127 |
Fin d'année 31 Décembre 2023 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|
Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Actions en circulation | 60,2M | 69,82M | 95,29M | 97,77M | 123,94M | 139,8M | 13,46M | 13,38M |
Fin d'année 31 Décembre 2023 | Sept 2021 | Déc 2021 | Mar 2022 | Juin 2022 | Sept 2022 | Déc 2022 | Mar 2023 | Juin 2023 |
---|---|---|---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Actions en circulation | 123,94M | 139,8M | N/A | N/A | N/A | 13,46M | N/A | N/A |
Return on Assets (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Equity (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Invested Capital (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Operating Margin (%) | N/A | N/A | -92.695 | N/A | N/A | N/A | -69.654 | N/A |
Net Profit Margin (%) | N/A | N/A | -94.858 | N/A | N/A | N/A | -71.99 | N/A |
Sales Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Book Value Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Earnings Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Cash Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Working Capital Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Operating Profit Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBIT Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBITDA Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Free Cash Flow Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Capitalisation boursière | 40,97M |
Ratio cours/bénéfice | -1,54 |
Ratio prix/ventes | 1,03 |
Ratio prix/liquidités | 2,43 |
Ratio prix/valeur comptable | 1,72 |
Rendement de dividende | - |
Actions en circulation | 15,46M |
Volume moyen (1 semaine) | 41,89k |
Volume moyen (1 mois) | 55,47k |
Variation sur 52 semaines | -60,49% |
Plus haut sur 52 semaines | 8,19 |
Plus bas sur 52 semaines | 2,05 |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales